Evidence map›Paper›PMID 42783096›Full record

ArticleClinics and practice2026

Patterns of Detecting Substances of Abuse in a Large Series of Patients in Spain During 2021-2025.

Carmen Lara-Apolinario, Cesar Martinez-Carral, Desiree Fischetti, Adexe J Fulgencio-González, Casimira Domínguez, Pedro C Lara

Abstract read
In one paragraph

Article in Clinics and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Carmen Lara-ApolinarioPreventive Medicine and Public Health Department, Infanta Elena University Hospital, 28342 Madrid, Spain.ORCID 0009-0003-2095-8451
Cesar Martinez-CarralMedicine Department, Fernando Pessoa Canarias University, 35450 Guía, Spain.
Desiree FischettiLaboratory Medicine Department, Dr. Negrín University Hospital, 35010 Las Palmas de Gran Canaria, Spain.ORCID 0009-0006-1927-4054
Adexe J Fulgencio-GonzálezLaboratory Medicine Department, Dr. Negrín University Hospital, 35010 Las Palmas de Gran Canaria, Spain.
Casimira DomínguezLaboratory Medicine Department, Dr. Negrín University Hospital, 35010 Las Palmas de Gran Canaria, Spain.
Pedro C LaraMedicine Department, Fernando Pessoa Canarias University, 35450 Guía, Spain.ORCID 0000-0003-1709-6232

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis study was conducted to assess, for the first time, patterns in common drugs of abuse detected in urine samples from a large series of patients treated at a tertiary university hospital and the role of age and sex in these patterns.

methodsThis study included samples from all patients analyzed at the Dr. Negrín University Hospital Laboratory from January 2021 to December 2025 with positive immunoassay test results for at least one of the following substances of abuse: cannabis, cocaine, amphetamine/methamphetamine, or opioids. The samples were anonymized, and only the patient's sex and date of birth were included in the analysis.

resultsIn total, there were 5019 positive results for at least one of the substances screened (cannabis, opioids, amphetamine, or cocaine). Women represented only 28.2% of all patients with a positive test (

conclusionsWith more than five thousand samples analyzed, our study sheds light on the profile of substance abuse in a large population of patients attending a university hospital. Our results can help to better adjust preventive political actions and medical care, in the context of substance abuse.

Indexed as

amphetaminecannabiscocaineimmunoassayopioidssubstance abuse

Identifiers

PMID42783096
PMCPMC13605693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.